# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001785530-22-000021
Filing Date
2022-05-10
Accepted
2022-05-10 07:04:39
Documents
50
Period of Report
2022-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | howl-20220331.htm iXBRL | 10-Q | 1232761
2 | EX-10.1 | a03312022ex101.htm | EX-10.1 | 587732
3 | EX-31.1 | a03312022ex311.htm | EX-31.1 | 9636
4 | EX-31.2 | a03312022ex312.htm | EX-31.2 | 9657
5 | EX-32.1 | a03312022ex321.htm | EX-32.1 | 7169
| Complete submission text file | 0001785530-22-000021.txt |  | 4816474

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | howl-20220331.xsd | EX-101.SCH | 22700
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | howl-20220331_cal.xml | EX-101.CAL | 33773
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | howl-20220331_def.xml | EX-101.DEF | 147028
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | howl-20220331_lab.xml | EX-101.LAB | 355997
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | howl-20220331_pre.xml | EX-101.PRE | 234358
44 | EXTRACTED XBRL INSTANCE DOCUMENT | howl-20220331_htm.xml | XML | 447655

Mailing Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138 617-952-0555
Werewolf Therapeutics, Inc. (Filer) CIK: 0001785530 (see all company filings)

EIN.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40366 | Film No.: 22907305
SIC: 2834 Pharmaceutical Preparations